At the conclusion of this knowledge-based activity, participants should be able to:
- Review appropriate and inappropriate utilization of proton-pump inhibitors (PPIs) in clinical practice.
- Discuss evidence in the literature favoring deprescribing of PPIs.
- Summarize recommended practice strategies for deprescribing PPIs.
- Identify the role of patient preference in the utilization of PPIs and barriers to deprescribing PPIs.Identify the role of patient preference in the utilization of PPIs and barriers to deprescribing PPIs.
- Given a patient case, recommend an appropriate deprescribing strategy and monitoring considerations for a patient on long-term PPI therapy.
“GERD” Practice Strategies:Deprescribing Proton Pump Inhibitors
For those interested in learning about “GERD” Practice Strategies:Deprescribing Proton Pump Inhibitors
Learning Objectives
At the conclusion of this knowledge-based activity, participants should be able to:
- Review appropriate and inappropriate utilization of proton-pump inhibitors (PPIs) in clinical practice.
- Discuss evidence in the literature favoring deprescribing of PPIs.
- Summarize recommended practice strategies for deprescribing PPIs.
- Identify the role of patient preference in the utilization of PPIs and barriers to deprescribing PPIs.Identify the role of patient preference in the utilization of PPIs and barriers to deprescribing PPIs.
- Given a patient case, recommend an appropriate deprescribing strategy and monitoring considerations for a patient on long-term PPI therapy.
UAN: 0203-0000-24-006-H01-P
Date of Expiration: January 15, 2025 at 11:59pm ET
Release Date: January 15, 2024
Speaker
Adrian Rodriguez,PharmD, BCGP
Tabular Rasa Healthcare
Clinical Specialist - Learning and Development
Financial Disclosure
We, Briana Skalski and David Wensel, declare to not have any real or apparent conflicts of interest or financial interests with any pharmaceutical manufacturers, medical device company, or in any product or service, including grants, employment, gifts, stock holdings, and honoraria related to the content of this presentation.
Briana Skalski is an employee of Tabula Rasa HealthCare. Each of the planning committee members has listed no financial interest/arrangement or affiliation that would be considered a conflict of interest.
CE Instructions
How to Claim Credit
BCGP Pharmacists: To ensure successful transfer of BCGP credit, your ASCP profile must be updated with your correct BCGP Credential Number and BPS-IND# prior to course completion. *Please note, any edit/updates made to your BCGP credential information in your ASCP profile after course completion requires a re-push, please submit your completed transcript to education@ascp.com for a manual upload.
CPE & BCGP Credit: You must complete the post-test and evaluation by the expiration date to receive credit. You have three attempts to achieve a 75% or higher on the 8-question post-test. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.
Target Audience
Senior Care Pharmacists who provide expert advice on the use of medications to individuals and older adults and are committed to providing person-centered care, considering the complex interrelationships between disease states, nutrition, medications, and other variables.
Accreditation
ASCP is approved by BPS as a provider for the recertification of BCGP.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Provider Contact Information
For questions about this educational activity, please contact ASCP at
education@ascp.com| Title | Credit Hours | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 |